| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |